Vactosertib, a TGF- receptor I kinase/ALK5 inhibitor, diminishes tumor progression and bone disease in a mouse model of multiple myeloma and overcomes resistance to proteasome inhibitors
Froehlich TE, Bogardus ST Jr., Inouye SK
This improvement was hypothesized to be attributed to its purported anti-inflammatory action, including a potential decrease in myeloperoxidase (MPO) activity and histological inflammatory cell influx
: Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500 : Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser : C212H350N56O78S : 4963.4408 g/mol CAS Number: 77591-33-4 : 4, -4, 4, TB 500, 500, -500, 500, Thymosin b4, Thymosin Beta-4, Thymosin Beta 4, TB-4, RGN-352, RGN-259, Timbetasin : BPC-157 + TB-500
Meier C, Carter LG, Winter G, Owens RJ, Stuart DI, Esnouf RM